New Research Report on United States Agribusiness Industry 2012

2012-10-30
Published : Oct-2012

US corn and soybean production is expected to fall significantly by the end of the harvest in October owing to the country’s worst drought in more than 50 years. This is likely to result in prices for those crops reaching record highs. The wheat crop was largely spared, although we expect production to moderate due to lower yields next year. High corn prices also led to a reduction in output growth for animal and ethanol products, leading us to revise our consumption forecasts significantly lower for 2012
and 2013. Regarding livestock, we see pig and cattle herds struggling over the short term due to high feed costs, with poultry showing the most promise. The US will remain the world’s largest food producer and exporter, although it will very likely relinquish the claim as the world’s largest soybean exporter (to Brazil) for the first time.

Key Trends
Soybean production growth to 2015/16: 10.4% to 100.0mn tonnes. This is mainly owing to the increase in poultry production over the long term. This will create production incentives by driving demand for soybean, which is used as feed. Furthermore, livestock production is still expanding globally, driving export demand. Corn consumption growth to 2015/16: about 4% annual average to 285.4mn tonnes. This will be driven by increases in ethanol production – though these will be less significant than in
the past few years – and increasing feed use in the later years of our forecast period as the livestock sector picks up. Poultry production growth to 2015/16: about 3% annual average to 22.4mn tonnes. The US is the world’s second largest poultry exporter behind Brazil. As such, increased global demand for poultry, particularly from emerging markets, will serve as a powerful production incentive.
2012 real GDP growth: 2.0%, forecast to average 2.2% from 2011-2016. Consumer price inflation: 1.7% year-on-year (August 2012), up from 1.4% in August 2011. United States Agribusiness Report Q4 2012 © Business Monitor International Ltd Page 6 Off The Peak S&PGS Grains Index Source: BMI, Bloomberg

Industry Outlook
We have revised down our US corn and soybean production forecasts for the 2012/13 season, as dry weather has led to the worst soil conditions in decades. Specifically, we have revised down our corn production estimates to 290mn tonnes, from a previous forecast of almost 330mn tonnes. By the end of August, nearly all major corn- and soybean-growing areas were under at least extreme drought levels (only exceptional droughts are considered more intense). We maintain our view that US wheat prices will fall slightly for the 2013/14 season (plantings for which begin in the coming months), although we see upside risks in the form of high prices that could encourage farmers to plant more, and good weather that has allowed corn harvests to accelerate.

We expect ethanol production in the US to remain subdued over the coming months. Recent weekly data from the US Energy Information Administration shows production picked up 13.6% week-on-week in mid-September as the corn harvest gathered pace. In fact, 26% of corn production was already harvested by September 16, which helped ethanol production to increase. That said, ethanol producers’ margins remain negative, which will limit production growth over the coming months. The US directed an average
of 40.9% of its corn crop to ethanol in the past four years in order to comply with the Environmental Protection Agency’s mandate to blend a set quantity of ethanol to gasoline every year. If the country directed the same quantity of corn to ethanol as in 2011/12 (about 126.6mn tonnes), it would leave between 44.0% and 47.0% (depending on the estimated use for the 2012/13 crop) of corn output
unavailable for food and feed use.

United States Agribusiness Report Q4 2012 © Business Monitor International Ltd Page 7 We maintain our forecast for US cotton production to increase 10.8% to 17.5mn bales in 2012/13 on the back of a larger area being harvested. Even though area planted will be 14% lower than in 2011/12, area harvested will be about 12.9% higher than in 2011/12. This is because of a national abandonment rate of only 14% in 2012/13, compared with 2011/12’s record of 36%. We do not see much impact from tropical storm Isaac on the country’s output, even though the storm hit the South, where most of the cotton plantations are located. The Cropcast weather service predicted there will be some wind and flooding damage to the cotton areas, mainly in northern Louisiana and south-eastern Arkansas. However, local industry sources indicated that the weather would not inflict permanent damage on the crop.

United States Agribusiness Industry 2012

Published: October 2012                      No. of Pages: 93                  Price:  US $ 1175

Buy Now

Table of Contents

Executive Summary 5
SWOT Analysis 8
United States Agriculture SWOT .. 8
United States Business Environment SWOT .. 8
Supply & Demand Analysis . 9
United States Grains Outlook 9
United States Dairy Outlook 13
United States Soybean Outlook 18
United States Sugar Outlook 22
United States Livestock Outlook .. 28
United States Cotton Outlook… 34
Commodity Price Analysis 38
Monthly Softs Update … 38
Cocoa: Momentum Waning 39
Coffee: Temporary Rally. 40
Cotton: Forming A Base . 42
Palm Oil: Underperforming The Complex .. 43
Sugar: Scope For A Moderate Rebound . 45
Monthly Grains Update … 48
Wheat: Little Relief From Southern Hemisphere 49
Corn: Looking The Weakest 50
United States Agribusiness Report Q4 2012
© Business Monitor International Ltd Page 4
Soybean: Prices To Stay Relatively Supported 52
Rice: Still The Underperformer .. 54
Upstream Analysis 56
Americas Machinery Outlook .. 56
Americas Fertiliser Outlook . 61
Americas GM Outlook . 64
Downstream Analysis … 68
Food. 68
Food Consumption .. 68
Confectionery.. 69
Canned Food .. 71
Dairy … 72
Drink 75
Alcoholic Drinks . 75
Beer 76
Spirits.. 77
Wine 77
Soft Drinks .. 78
Hot Drinks .. 81
Trade … 82
Mass Grocery Retail 83
Country Snapshot . 86
BMI Forecast Modelling 90

Filed in: Biotechnology
More Reports
Title Price Buy Now

Stem Cell Assays Market by Type (Viability, Proliferation, Differentiation, Apoptosis), Cell Type (Mesenchymal, iPSCs, HSCs, hESCs), Product & Service (Instrument), Application (Regenerative Medicine, Clinical Research), End User – Global Forecast to 2027

“The stem cell assays market growth can be attributed to factors such as the rising demand for technologically advanced stem cell analysis instruments, increase in the prevalence of cancer & other diseases and rising number of biopharma and & biotechnology companies working on stem cell based therapies.” The stem cell assays market is projected to reach USD 4.5 Billion by 2027 from USD 1.9 Billion in 2022, at a CAGR of 17.7% during the forecast period. The growth of the market is projected to be driven by collaborations and agreements among market players for stem cell assay products & services, launch of new stem cell analysis systems such as flow cytometers and increase in R&D expenditure by biopharmaceutical and biotechnology companies. The viability/cytotoxici......
$

Nucleic Acid Isolation & Purification Market by Product (Kit, Reagent, Instrument), Method (Column, Magnetic Beads), Type (Genomic DNA, Plasmid DNA, miRNA), Application (Drug Discovery, Diagnostics), End User (Pharma, Biotech) – Global Forecast to 2027

The nucleic acid isolation and purification market is expected to grow at a CAGR of 7.9% in the forecast period. The global nucleic acid isolation and purification market is projected to reach USD 9.2 billion by 2027 from USD 6.3 billion in 2022, at a CAGR of 7.9% during the forecast period. The growth of this market can majorly be attributed to the increasing R&D activities as well as technological advancements and increasing automation. The emerging economies, improving regulatory and reimbursement scenario, and the growing adoption of molecular diagnostics and personalized medicines are expected to offer a wide range of growth opportunities for players in the market. However, the high cost of automated instruments is expected to hinder the growth of the market. As the world be......
$4950

Wound Care Biologics Market by Product (Biological Skin Substitutes, Topical Agents), Wound Type (Ulcers [Diabetic Foot, Venous, Pressure Ulcers], Surgical & Traumatic Wounds, Burns), End User (Hospitals, ASCs, Burn Centers) – Global Forecast to 2027

“Rising number of road accidents and associated traumatic wounds and growing incidence of burn injuries are driving the overall growth of the wound care biologics market” The global wound care biologics market is valued at an estimated USD 1.8 billion in 2022 and is projected to reach USD 2.4 billion by 2027, at a CAGR of 5.4% during the forecast period. Market growth is driven by factors such as the growing incidence of burn injuries and the rising number of road accidents and associated traumatic wounds. However, the high cost of wound care biologic products and the risk associated with skin substitute failure are the major factors hampering the growth of this market. “The biological skin substitutes segment accounted for the highest growth rate in the wound care biologics ma......
$4950

Bioanalytical Testing Services Market by Type, Application (Oncology, Neurology, Infectious Diseases, Gastroenterology, Cardiology), End User and Region (North America, Europe, APAC, Latin America, MEA) – Global Forecast to 2027

“The global bioanalytical testing services market is projected to grow at a CAGR of 15.6%” Bioanalytical testing involves analytical methods used for the detailed examination of biological and biotechnology products. Bioanalysis enables the quantitative measurement of drugs and their metabolites, biological molecules in unnatural locations or concentrations, DNA, and large molecules. The global bioanalytical testing services market is projected to reach USD 6.0 billion by 2027 from an estimated USD 2.9 billion in 2022, at a CAGR of 15.6% during the forecast period. “The Cell-based assays segment is expected to account for the largest share of the bioanalytical testing services market” The increasing prevalence of chronic diseases and the rising number of clinical trials ar......
$4950

Cell Analysis Market by Product & Service (Reagents & Consumables, Instruments), Technique (Flow Cytometry, High Content Screening), Process (Single-cell Analysis), End User (Pharmaceutical and Biotechnology Companies) – Global Forecast to 2027

“Single-cell analysis segment has gained significant traction in the recent years attributed to the widening applications of this technology in cancer research. This is further supplemented by the robust government initiatives targeted towards single-cell analysis research. The growth of the single-cell analysis segment is expected to drive the overall growth of the cell analysis market.” The global cell analysis market is projected to reach USD 28.6 Billion by 2027 from USD 17.7 Billion in 2022, at a CAGR of 10.1% during the forecast period. Key opportunities for the cell analysis market include, emerging economies, high risk of communicable diseases and pandemic outbreak, and increasing adoption of novel cellular assays in various cancer research applications. On the other hand, h......
$4950

3D Cell Culture Market by Type (Hydrogel, ECM, Hanging Drop, Bioreactor, Microfluidics, Magnetic Levitation), Application (Cancer, Stem Cell, Toxicology, Tissue Engineering), End User (Pharma, Biotech, Research, Cosmetics), Region – Global Forecast to 2027

“Increasing focus on developing alternative methods to animal testing, growing focus on personalized medicine is driving the overall growth of the3D Cell culture market” The global 3D cell culture market is valued at an estimated USD 1.3 billion in 2022 and is projected to reach USD 2.6 billion by 2027, at a CAGR of 15.6% during the forecast period. The growth of this market is mainly driven by factors such as the increasing focus on developing alternative methods to animal testing, growing focus on personalized medicine, increasing incidence of chronic diseases, and the availability of funding for research. On the other hand, a lack of infrastructure for 3D cell-based research and the high cost of cell biology research are expected to restrain the growth of this market during the f......
$4950

Tangential Flow Filtration Market by Product (System, Membrane Filter), Material (PES, PVDF, PTFE), Technique (Ultrafiltration), Application (Final Product Processing, Raw Material Filtration), End User (Pharma, Biotech), Region – Global Forecast to 2027

“Growth in the tangential flow filtration market can be attributed to factors such as the growing advantages of tangential flow filtration over normal flow filtration, rising R&D spending in pharmaceutical & biotechnology industries and increasing adoption of single-use technologies.” The global tangential flow filtration market is projected to USD 2.8 billion by 2027 from USD 1.5 billion in 2022, at a CAGR of 13.2% during the forecast period. The rising advantages of tangential flow filtration over normal flow filtration, increasing adoption of single-use technologies, and growing R&D spending in pharma-biotech companies. On the contrary, the high capital investments for setting up new production facilities are expected to restrain the market growth. “In 2021 the s......
$4950

Human Microbiome Market by Product (Prebiotics, Probiotics, Food, Diagnostic Tests, Drugs), Application (Therapeutic, Diagnostic), Disease (Infectious, Metabolic/Endocrine), Research Technology (Genomics, Proteomics, Metabolomics) – Global Forecast to 2029

“Increased focus on human microbiome therapy development to drive the growth of this market.” The human microbiome market is projected to reach USD 1,370 million by 2029 from USD 269 million in 2023, at a CAGR of 31.1% from 2023 to 2029. The major factor driving the growth of the human microbiome market is the increasing focus on human microbiome therapy development. The human microbiome as a validated target for drug development & development of human microbiome-based tests for early disease detection and diagnosis are also factors expected to support market growth. However, a lack of expertise and inadequate research on the human microbiome are factors expected to restrain this market's growth. “By product segment, the drugs segment accounted for the largest share of huma......
$4950

Exosome Research Market by Product and services (Kits, Reagents, Instrument), Indication (Cancer, Infectious Diseases), Application (Biomarkers, Vaccines), Manufacturing Services (Stem cell, Dendritic cell-derived), End User – Global Forecast to 2026

“Increasing interest in exosome-based proceduresto Drive the Growth of Market” The exosome research market is valued at an estimated USD 144 million in 2021 and is projected to reach USD 661 million by 2026, at a CAGR of 35.6% during the forecast period, owing to increased funding for life sciences research, the high global prevalence of cancer, and the increasing interest in exosome-based procedures. “By product & service, the kits & reagents segment accounted for the largest share of the exosome research market” Based on product and service, the exosomes market is segmented into kits & reagents, instruments, and services. The kits & reagents segment is further divided into antibodies, isolation, purification, quantitation kits & reagents, and other ki......
$4950

Metagenomic Sequencing Market by Product & Services (Reagent, Consumables, Instrument), Workflow (Sample Preparation, Sequencing), Technology (16S rRNA, Shotgun, Whole-genome), Application (Drug Discovery, Diagnostic) – Global Forecast to 2027

“Continuous technological innovations in NGS platforms is the key factors driving growth in the metagenomic sequencing market’’ The metagenomic sequencing market is expected to reach USD 4.3 billion by 2027 from USD 1.9 billion in 2022, at a CAGR of 18.4% during the forecast period. Growth in the metagenomic sequencing market is mainly driven by continuous technological innovations in NGS platforms, increasing initiatives and funding from government & private bodies for large-scale sequencing projects, declining costs of genome sequencing, and the significant applications of metagenomics in various fields. “By technology segment, the shotgun metagenomic sequencing segment accounted for the fastest-growing segment of the metagenomic sequencing market” Based on technol......
$4950
We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy